Significance of acquired diverticular disease of the vermiform appendix: a marker of regional neoplasms?

J Clin Pathol. 2012 Jul;65(7):638-42. doi: 10.1136/jclinpath-2011-200647. Epub 2012 Mar 29.

Abstract

Aim: To assess the prevalence of acquired diverticulum of the appendix (DA), including incipient forms and its possible significance as a marker of local/regional neoplasms.

Materials and methods: The pathology database at Hvidovre Hospital was searched for appendix specimens, received between 2001 and 2010, coded for DA or for a space-occupying lesion. Slides were reviewed to determine DA status and the nature of lesions possibly causing DA.

Result: Among 4413 appendix specimens, DA were identified in 39 (0.9%, CI 0.6% to 1.2%) cases, 17 (43.6%, 28.0% to 59.2%) of which additionally harboured an appendiceal neoplasm/neoplastic precursor, whereas this figure was 1.2% (CI 0.9% to 1.6%) for non-DA specimens (p<0.0001). Six of the 39 DA specimens comprised incipient DA, three of which coexisted with appendiceal neoplasms. In addition, local/regional non-neoplastic lesions (six cases) and colorectal carcinomas (four cases) coexisted with DA.

Conclusion: DA has significance as a putative marker of local/regional neoplasms. Therefore, a DA specimen proved significantly more likely to harbour a neoplastic growth than a non-DA counterpart. Submission for microscopy of the entire DA specimen, whether transmural or only incipient, and a comment in the pathology report on the occasional concurrence of local/regional neoplasms in this setting seem appropriate. The observation of DA may thus provide a valuable contribution in the diagnostic process.

MeSH terms

  • Appendiceal Neoplasms / epidemiology*
  • Appendix / pathology*
  • Biomarkers, Tumor
  • Cecal Diseases / diagnosis*
  • Cecal Diseases / epidemiology*
  • Cecal Diseases / pathology
  • Colorectal Neoplasms / epidemiology*
  • Comorbidity
  • Data Collection
  • Diverticulum / diagnosis*
  • Diverticulum / epidemiology*
  • Diverticulum / pathology
  • Humans
  • Prevalence
  • Prospective Studies
  • Retrospective Studies
  • Risk Factors

Substances

  • Biomarkers, Tumor